Innophos to share in-vitro study results on Chelamax chelated magnesium at SupplySide West 2024
Innophos will also highlight the latest research findings on chelated minerals.
Image courtesy of Innophos
In a recent press release, Innophos announced it will present new in vitro research on the benefits of chelated minerals at SupplySide West in Las Vegas, NV. Led by Robert Finn, PhD, nutrition R&D director for Innophos, the presentation will take place at a Breakfast Brief on Wednesday, October 30, from 9 to 10 a.m. where he will explain the higher absorption of Chelamax Magnesium products and maximizing magnesium for absorption in tablets, capsules, and gummies.
"Innophos is leading the way in advancing the science of chelated minerals,” stated Dr. Finn, in the press release. “Our latest in vitro study confirms the superior absorption rates of Chelamax chelated magnesium. I am excited to meet with attendees and share our new findings.”
Innophos will be at Booth #3880 and will showcase their three-step verification process for confirming full mineral chelation, plus the bioaccessibility and bioavailability offered by organically bound minerals. They will also introduce their whitepaper on their latest research.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
